
-
TherapeuticsMD NASDAQ:TXMD TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.
Location: 951 W Yamato Rd Ste 220, Florida, 33431-4440, United States | Website: www.therapeuticsmd.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
17.35M
Cash
5.047M
Avg Qtr Burn
-1.78M
Short % of Float
1.83%
Insider Ownership
1.71%
Institutional Own.
30.61%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TX-004HR: IMVEXXY™ (estradiol vaginal inserts) Details Dyspareunia (Moderate to Severe) | Approved Quarterly sales | |
ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) Details Birth Control (Contraception) | Approved Quarterly sales | |
TX-001HR: BIJUVA™ (Estradiol and Progesterone) Details Moderate to Severe Vasomotor Symptoms Due to Menopause | Approved Quarterly sales |